Etropal AD operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Etropal AD with three other
medical equipment manufacturers in Europe:
Safe Orthopaedics SAS
sales of 3.47 million Euro [US$3.85 million]
of which 61%
was Direct Sales),
(6.52 million Euro [US$7.22 million]
of which 100%
was Implants and Surgical instruments), and
Pixium Vision Sa
based in France
(1.60 million Euro [US$1.77 million]
During the year ended December of 2018, sales at
Etropal AD were 8.30 million Bulgarian Lev (US$4.70 million).
increase of 12.1%
versus 2017, when the company's sales were 7.40 million Bulgarian Lev.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Etropal AD had sales
of 8.42 million Bulgarian Lev.